Working… Menu
Trial record 11 of 1215 for:    HISTAMINE

A Study of HDC/IL-2 Treatment in Chronic Myelomonocytic Leukemia (CMML)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03040401
Recruitment Status : Recruiting
First Posted : February 2, 2017
Last Update Posted : December 19, 2017
Sahlgrenska University Hospital, Sweden
Karolinska University Hospital
Nordic MDS Group
Information provided by (Responsible Party):
Vastra Gotaland Region

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : December 15, 2018
Estimated Study Completion Date : December 15, 2019